
Johnson & Johnson
JNJ·NYSE
JNJ stock price change
On the last trading day, JNJ stock closed at 203.84 USD, with a price change of 1.10% for the day.
Buy stocks with cryptoJNJ key data
Previous close203.84 USD
Market cap491.11B USD
Volume1.74M
P/E ratio19.67
Dividend yield (TTM)2.55%
Dividend amount1.30 USD
Last ex-dividend dateAug 26, 2025
Last payment dateSep 09, 2025
EPS diluted (TTM)10.36 USD
Net income (FY)14.07B USD
Revenue (FY)88.82B USD
Next report dateJan 21, 2026
EPS estimate2.530 USD
Revenue estimate24.15B USD
Shares float2.41B
Beta (1Y)0.17

Johnson & Johnson overview
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, womens health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Sector
Health technology
Industry
Pharmaceuticals: Major
CEO
Joaquin Duato
Headquarters
New Brunswick
Website
jnj.com
Founded
1887
Employees (FY)
139.8K
Change (1Y)
+7.9K +5.99%
Revenue / Employee (1Y)
635.33K USD
Net income / Employee (1Y)
100.62K USD




